Results of the Cystic Fibrosis HealthHub Trial
In this webinar, Dr Martin Wildman explains why preventative therapy for Cystic Fibrosis patients is even more important than before, especially in the light of improvement in their lung health by taking cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
Dr Wildman highlights the importance of sustained self-care in Cystic Fibrosis and provides an overview of the CF HealthHub program: how it helps Cystic Fibrosis patients to continue to take preventative therapy with the aim of helping build habits and develop adherence to treatments.
We hope that you found the content valuable. To ensure that we continue to provide topics and content of interest, we would very much value your feedback by completing a short questionnaire.
Dr Martin Wildman
Consultant in Respiratory Medicine & Adult CF